CTRI/2014/10/005081尚未招募2 期
A Clinical Evaluation of Triphala Guggulu and Kasisadi Taila in the management of Arsha (Haemorrhoids). - CETKMA
Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of either sex aged 16 â??60 years.
- •2.Presence of 1st, 2nd & 3rd degree Arsha (Hemorrhoids) confirmed by clinical / proctoscopic / colonoscopic examination (With or without bleeding / painful or painless).
- •3.Willing and able to participate in the study for 06 weeks
排除标准
- •1.Age below 15 years & above 60 years
- •2.Thrombosed & Strangulated pile mass (Hemorrhoids)
- •3.Bleeding diathesis
- •4.Cirrhosis of Liver- Portal hypertension
- •5.Ulcerative colitis / Crohnâ??s disease
- •6.Patients with evidence of malignancy
- •7.Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, immunosuppressants, estrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study.
- •8.Patients suffering from major systemic illness necessitating long term drug etc.
- •9.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome,
- •10.Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •11.Symptomatic patient with clinical evidence of Heart failure.
- •12.Patients having uncontrolled Diabetes Mellitus (Blood Sugar Fasting > 250mg/dl).
- •13.Patients with concurrent serious hepatic disorder (defined as aspartate aminotransferase (AST) and / or alanine aminotransferase (ALT), total bilirubin or alkaline phosphatase (ALP) > 2 times upper normal limit) or renal disorders (defined as S.creatinine >1.2mg/dL), severe pulmonary dysfunction (uncontrolled asthma and chronic obstructive pulmonary disease [COPD]), inflammatory bowel
- •14.Disease or any other condition that may jeopardize the study..
- •15.Pregnant/ lactating females.
- •16. Patients on oral contraceptives.
- •17.Alcoholics and/or drug abusers.
- •18.H/o hypersensitivity to any of the trial drugs or their ingredients.
- •19.Patients who have completed participation in any other clinical trial during the past six (06) months.
- •20.Any other condition which the Investigator thinks may jeopardize the study.
研究者
相似试验
已完成
2 期
A Comparative Clinical Study of Gokshuradi guggulu and Pramehahara guggulu in the management of Madhumehjanya updrava (Diabetic Nephropathy)CTRI/2020/03/024321Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar28
尚未招募
不适用
The study of Ayurvedic Classical formulations in Benign Prostatic Hyperplasia.CTRI/2018/01/011287J S Ayurved college Nadiad
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the patients of Prostate enlargement.CTRI/2012/04/002586Department of AYUSH Ministry of Health Family Welfare Government of India150
招募中
3 期
Study of Kaishore Guggulu and Balaguduchyadi Taila in the Management of Gout.CTRI/2018/04/013326CCRAS
尚未招募
2 期
To assess the effect of Ayurvedic medicines on goutCTRI/2021/09/036364Central Council for Research in Ayurvedic Sciences CCRAS